Boston Scientific Corporation (NYSE:BSX) Q4 2023 Earnings Call Transcript

Boston Scientific Corporation (NYSE:BSX) Q4 2023 Earnings Call Transcript January 31, 2024 Boston Scientific Corporation beats earnings expectations. Reported EPS is $0.55, expectations were $0.51. BSX isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning and welcome to the […]

Related Keywords

Japan ,Daniel Brennan ,Lauren Tengler ,Jon Monson ,Hedge Fund ,Access Solutions ,Structural Heart Valves ,Single Arm Continued Access ,Rhythm Management ,Global Controller ,Chief Accounting Officer ,Investor Relations ,Sally Devoe ,Hedge Fund Manager Charles Paquelet ,Boston Scientific Corporation ,Fourth Quarter ,Dan Brennan ,Basis Points ,Organic Growth ,Operational Revenue ,Operating Margin ,Mike Mahoney ,Operational Revenue Growth ,